pharmaceuticals, including protein-based and other pharmaceuticals for use in treating diseases, including inflammatory diseases, chronic skin ulcers, neurological disorders, rheumatoid arthritis, sepsis and septic shock, leukemia, cystic fibrosis, genetic emphysema and peripheral neuropathies, sepsis syndrome; systemic inflammatory response syndrome ( SIRS) due to sepsis; pancreatitis; burns and cachexia; asthma; inflammatory bowel disease; graft versus host disease; and stroke; IL-1 mediated diseases

'-1':61 'arthriti':23 'asthma':50 'base':5 'bowel':52 'burn':47 'cachexia':49 'chronic':17 'cystic':29 'diseas':13,16,53,57,63 'disord':21 'due':43 'emphysema':32 'fibrosi':30 'genet':31 'graft':54 'host':56 'il':60 'includ':2,14 'inflammatori':15,39,51 'leukemia':28 'mediat':62 'neurolog':20 'neuropathi':35 'pancreat':46 'peripher':34 'pharmaceut':1,8 'protein':4 'protein-bas':3 'respons':40 'rheumatoid':22 'sepsi':24,36,45 'septic':26 'shock':27 'sir':42 'skin':18 'stroke':59 'syndrom':37,41 'system':38 'treat':12 'ulcer':19 'use':10 'versus':55

ANTRIL

Owner

Goods & Services